BlossomHill Therapeutics (BLSM) shares fell 2.3% to $15.63 in their Nasdaq debut on Friday.
The stock opened at $15.75 and reached $16 before trading as low as $15.25.
The company priced its upsized initial public offering of 9.375 million common shares at $16 each, raising $150 million in gross proceeds.
The underwriters were granted a 30-day option to buy up to an additional 1.4 million shares.
The offering is expected to close Monday.
Price: $15.63, Change: $-0.37, Percent Change: -2.31%
Century Aluminum (CENX) reported Q2 adjusted earnings late Thursday of $2.46 per diluted share, up from $0.30 a year earlier.Three analysts polled by FactSet expected $2.33.Revenue for the three months ended June 30 rose to $752.1 million from $628.1 million a year earlier.Four analysts surveyed by FactSet expected $817.2 million.The company's shares rose 1.6% in after-hours trading.
JFrog (FROG) reported Q2 non-GAAP earnings late Thursday of $0.27 per diluted share, up from $0.18 a year earlier.Analysts polled by FactSet expected $0.24.Revenue in the three months ended June 30 rose to $163.8 million from $127.2 million a year earlier.Analysts projected $155.6 million.The company expects Q3 non-GAAP EPS of $0.22 to $0.24 on revenue of $164 million to $166 million. Analysts project EPS of $0.22 on revenue of $159 million.JFrog boosted full-year guidance to non-GAAP EPS of $0.96 to $1.00 on revenue of $648 million to $652 million. The prior forecast was EPS of $0.93 to $0.97 on revenue of $628 million to $632 million.Analysts expect EPS of $0.95 on revenue of $632.9 million.JFrog shares jumped 13% in after-hours trading.
Reinsurance Group of America (RGA) reported Q2 adjusted earnings late Thursday of $8.89 per diluted share, up from $4.72 a year earlier.Analysts polled by FactSet expected $6.50.Revenue in the three months ended June 30 rose to $6.64 billion from $5.6 billion a year earlier.Analysts projected $6.67 billion.The company's shares rose 1.6% in after-hours trading.